Endometrial Cancer Human Endometrium Total RNA, Donor 1521 (CAT#: DBFF-0624-HY4774)

Datasheet

Overview

Endometrial cancer is a malignant tumor that occurs in the lining of the uterus and is mainly caused by excessive proliferation of endometrial cells. It is a relatively common gynecological cancer that usually occurs in postmenopausal women. Endometrial Cancer Human Endometrium Total RNA, Donor 1521 is extracted from endometrium tissue of a single endometrial cancer human donor using a classical guanidine isothiocyanate-phenol: chloroform extraction method. RNA goes through rigorous quality control procedures to ensure the highest quality possible.

Product Summary

Quantity:

* For Research Use Only. Not For Clinical Use.

Donor Information

Gender

Female

Age At Sampling

54 yrs

Race

White or Caucasian

Medical Diagnosis

Adenocarcinoma of endometrium, endometrioid

Product Description

Species

Human

Tissue Name

Endometrium

Sample Diagnosis Category

Endometrial Cancer

28S/18S Ratio

1.64

Size

5 µg

Shipping

Dry ice

Storage

Stored at -80°C without repeated freeze and thaws

Applications

Northern blotting, ribonuclease protection assay, polymerase chain reaction analysis, rapid amplification of cDNA end analysis, cDNA synthesis, RNA differential display, microRNA studies, and RNA library construction.

Product Properties

Metastatic Site

Uterus

Normal Ratio

Lesional Ratio

Tumor Ratio

85%

Hypocellular/Acellular Tumor Stroma Ratio

10%

Hypercellular Tumor Stroma Ratio

Necrosis Ratio

H&E Staining Pathological Verification

Cellular tumor stroma: 90% desmoplasia, 10% mixed inflammatory cells; Lesion: endometrium with complex hyperplasia

Histopathological Grade

FIGO G2: Moderately differentiated

Tumor Stage

Primary Tumor (T)

T1b

Regional Lymph Node (N)

Distant Metastasis (M)

Technical Specifications

Quality Control

Tested by spectrophotometer and denatured agarose gel electrophoresis

For Research Use Only | Not For Clinical Use